StopDown
Funding · 25 March 2026Fullife Healthcare₹300 Cr ($32 Mn)Nutrition and wellness brands operator

Fullife Healthcare raises ₹300 Cr in Series D

By · Editor ·

Series DFounded 2011
  • Fullife Healthcare runs nutrition brands Fast&Up, Chicnutrix, and NightOut
  • It raised ₹300 Cr ($32 Mn) in a Series D led by Elev8 Venture Partners
  • The company plans to expand into digestive health and sleep support

What happened

  • Fullife Healthcare raised ₹300 Cr ($32 Mn) in a Series D round.
  • The round was led by Elev8 Venture Partners, its first D2C investment.
  • Elev8's limited partners also participated in the round.
  • The company operates Fast&Up (active nutrition), Chicnutrix (beauty nutrition), and NightOut (hangover relief).
  • Funds will support expansion into digestive health, sleep support, and protein-based nutrition.
  • The company also plans to scale manufacturing, distribution, and retail presence.
  • It will invest in new delivery formats and product innovation.

Why it matters

  • The D2C health and wellness space is expanding rapidly, with legacy brands entering.
  • Competitors include Plix, Wellbeing Nutrition, and Oziva.
  • Dabur launched digital-first brand Siens last year.
  • Marico owns a majority stake in Plix.
  • USV acquired 79% of Wellbeing Nutrition for ₹1,583 Cr ($174.7 Mn).

The business

  • Fullife Healthcare operates Fast&Up, a brand of effervescent tablets for weight loss, daily nutrition, hydration, and energy.
  • Fast&Up has expanded into protein, pre-workout, and drink mixes.
  • Chicnutrix offers skincare products like serums, face masks, and effervescent tablets with glutathione and keratin.
  • NightOut sells effervescent tablets for hangover relief.
  • The company has over 100 SKUs across hydration, metabolic health, sports nutrition, and beauty wellness.
  • It has a manufacturing facility in Maharashtra and develops products with foreign pharmaceutical companies.
  • Fullife sells in over 40 countries, focusing on the US, Europe, and Gulf regions.

The founders

Varun Khanna

CEO and Founder
  • Founded the company in 2011.
  • Serves as CEO.

Who put in money

In numbers

₹300 CrSeries D amount · 2026
$32 MnSeries D amount (USD) · 2026
100+SKUs
40+Countries present
$30 Mn+Prior funding
$22 MnSeries C amount · 2021
$72 Mn+Total raised
₹256.04 CrFY25 operating revenue · 2025
₹187.64 CrFY24 operating revenue · 2024
₹13.42 CrFY25 losses · 2025
₹30.16 CrFY24 losses · 2024

What happens next

  • Expand into digestive health, sleep support, and protein-based nutrition.
  • Scale manufacturing and distribution, deepen retail presence, and improve digital consumer access.
  • Invest in new delivery formats and product innovation.

Earlier rounds

  • 2021 · Series C · $22 Mn · led by Morgan Stanley Private Equity Asia (MSPEA)

Up against

PlixWellbeing NutritionOziva

Words to know

D2C
Direct-to-consumer, selling products directly to customers without intermediaries.
SKU
Stock keeping unit, a unique identifier for each product variant.
Effervescent tablets
Tablets that dissolve in water to create a fizzy drink.
FMHG
Fast-moving health goods, consumer health products sold quickly.

The numbers around it

Healthcare & Life Sciences in March 2026: 16 rounds with a disclosed amount, $134 million in all; the biggest was Cult.fit (₹440 Cr ($47.2 Mn)). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Series B/C: Series B, C, D and later rounds are growth rounds: large cheques for a startup with a proven model that wants to expand, enter new markets or move toward profit and a listing. In India they are usually priced in CCPS and, when foreign investors take part, must follow FEMA pricing rules.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

Everything on Fullife Healthcare → · All startup news on 25 March 2026 →

Is this Fullife Healthcare? Get your “Featured on StopDown” badge →